The chance of a second breast cancer is higher among some Hawai'ian women
https://www.facingourrisk.org/XRAY/breast-cancer-after-DCIS-among-Hawaiian-women
Full article: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2785310
Women diagnosed with ductal carcinoma in situ (DCIS), an early form of breast cancer, are more likely to have a second breast cancer diagnosis if they are of Native Hawai'ian, Filipino or Japanese ancestry than women of other racial or ethnic groups. (posted 3/15/22)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- I have DCIS and am of Native Hawai'ian, Filipino or Japanese ancestry. What is my risk of a second breast cancer?
- What treatment for DCIS best fits my personal and family history?
- Would I benefit from genetic counseling?
- How does my age at diagnosis affect my DCIS treatment?
- What are the risks or benefits of different treatments for DCIS?
Open Clinical Trials
The following clinical research studies focus on addressing health disparities in cancer.
- NCT04854304: Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts. This study is looking at how effectively a FAST breast MRI can successfully detect breast cancer in Black women with dense breasts.
- NCT03640208: Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans. This research will study a community-based intervention to educate and overcome barriers to screening among African Americans who are 45 years or older with no personal or family history of colorectal cancer or inflammatory bowel disease.
- NCT04392050: A Community-Based Educational Intervention to Improve Colorectal Cancer Screening. This study will look at what makes it easy or difficult for underserved populations to have colorectal cancer screenings, with a focus on African American, Latinx and Asian people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.